Download PDF
Synlett 2005(8): 1322-1324  
DOI: 10.1055/s-2005-868476
LETTER
© Georg Thieme Verlag Stuttgart · New York

Solid-Phase Synthesis of Disubstituted 1,3-Dihydro-2H-imidazol-2-ones

M. Patek*, A. S. Weichsel, B. Drake, M. Smrcina
Sanofi-Aventis Center for Combinatorial Technologies, 1580 E. Hanley Blvd., Tucson, Arizona 85737, USA
Fax: +1(520)5758283; e-Mail: Marcel.Patek@sanofi-aventis.com;
Further Information

Publication History

Received 23 February 2005
Publication Date:
21 April 2005 (online)

    Permissions and Reprints All articles of this category

Abstract

An efficient and straightforward solid-phase synthesis of sulfonylimidazolones 2a-g is described. Our design was directed toward obtaining molecules for a general library development and incorporates functionalities that fulfill lead-like criteria. The synthesis was realized with the use of SPOS in fair to good yields and purity. Monitoring and quantitation of intermediates and final products were performed by the use of LCMS and NMR spectroscopy.

Key words

imidazolones - solid-phase synthesis - acyliminium ion - nucleophiles - combinatorial chemistry

    References

  • 1a Cheng J.-F. Kaito C. Chen M. Arrhenius T. Nadzan A. Tetrahedron Lett.  2002,  43:  4571 
    CrossrefGoogle Scholar
  • 1b Lee SH. Clapham B. Koch G. Zimmermann J. Janda KD. Org. Lett.  2003,  5:  511 
    CrossrefGoogle Scholar
  • 1c Lee SH. Yoshida K. Matsushita H. Clapham B. Koch G. Zimmermann J. Janda KDJ. Org. Chem.  2004,  6:  4627 
    CrossrefGoogle Scholar
  • For the solid-phase synthesis of related imidazolidones, see:
  • 1d Nefzi A. Ostrech JM. Giulanotti M. Houghten RA. J. Comb. Chem.  1999,  1:  195 
    CrossrefGoogle Scholar
  • 1e Goff D. Tetrahedron Lett.  1998,  39:  1477 
    CrossrefGoogle Scholar
  • 2a Grimmett MR. Comprehensive Heterocyclic Chemistry   Vol. 5:  Potts KT. Pergamon Press; Oxford: 1984.  p.457 
    Google Scholar
  • 2b Winkler JD. Fonteh AN. Sung CM. Heravi JD. Nixon AB. Chabot-Fletcher M. Griswold D. Marshall LA. Chilton FH. J. Pharmacol. Exp. Ther.  1995,  274:  1338 
    Google Scholar
  • 3 Andres JI. Alonso JM. Diaz A. Fernandez J. Iturrino L. Martinez P. Matesanz E. Freyne EJ. Deroose F. Boeckx G. Petit D. Diels G. Megens A. Somers M. Van Wauwe J. Stoppie P. Cools M. De Clerck F. Peeters D. de Chaffoy D. Bioorg. Med. Chem. Lett.  2002,  12:  653 
    CrossrefGoogle Scholar
  • 4 Parmee ER. Naylor EM. Perkins L. Colandrea VJ. Ok HO. Candelore MR. Cascieri MA. Deng L. Feeney WP. Forrest MJ. Hom GJ. MacIntyre DE. Miller RR. Stearns RA. Strader CD. Tota L. Wyvratt MJ. Fisher MH. Weber AE. Bioorg. Med. Chem. Lett.  1999,  9:  749 
    CrossrefGoogle Scholar
  • 5 Karabelas K, Lepisto M, and Sjo P. inventors; WO Patent  0078750.  ; Chem. Abstr. 2001, 134, 71594
  • 6 Carling RW. Moore KW. Moyes CR. Jones EA. Bonner K. Emms F. Marwood R. Patel S. Patel S. Fletcher AE. Beer M. Sohal B. Pike A. Leeson PD. J. Med. Chem.  1999,  42:  2706 
    CrossrefPubMedGoogle Scholar
  • 7a Reitz DB. Garland DJ. Norton MB. Collins JT. Reinhard EJ. Manning RE. Olins GM. Chen ST. Palomo MA. Bioorg. Med. Chem. Lett.  1993,  3:  1055 
    Google Scholar
  • 7b Olins GM. Chen ST. McMahon EG. Palomo MA. Reitz DB. Mol. Pharmacol.  1995,  47:  115 
    Google Scholar
  • 8 Yamada M. Ichinowatari G. Tanimoto A. Yaginuma H. Ohuchi K. Life Sci.  1998,  62:  297 
    Google Scholar
  • 9a Duschinsky R. Dolan LA. J. Am. Chem. Soc.  1946,  68:  2350 
    Google Scholar
  • 9b Jackman M. Klenk M. Fishburn B. Tullar BF. Archer S. J. Am. Chem. Soc.  1948,  70:  2884 
    Google Scholar
  • 9c Bader H. Downer JD. J. Chem. Soc.  1953,  1636 
    Google Scholar
  • 9d Doney JJ. Altland HW. J. Heterocycl. Chem.  1979,  16:  1057 
    Google Scholar
  • 9e Haines DR. Leonard NJ. Wiemer DF. J. Org. Chem.  1982,  47:  474 
    Google Scholar
  • 10a Butler AR. Hussain J. J. Chem. Soc., Perkin Trans. 2  1981,  22:  2431 
    Google Scholar
  • 10b Hough TL. Hough IR. Pannell RW. J. Heterocycl. Chem.  1986,  23:  1125 
    Google Scholar
  • 10c Zavyalov SI. Sitkareva IV. Ezhova GI. Dorofeeva OV. Zavozin AG. Khim. Getero. Soed.  1990,  847 
    Google Scholar
  • 10d Kim YB. Kim CS. Lee CK. J. Heterocycl. Chem.  1994,  31:  1653 
    Google Scholar
  • 11a Wong O. Tsuzuki N. Richardson M. Rytting H. Konishi R. Higuchi T. Heterocycles  1987,  26:  3153 
    CrossrefGoogle Scholar
  • 11b Lee YS. Kim CS. Park H. Heterocycles  1994,  38:  2605 
    CrossrefGoogle Scholar
  • 11c Wendeborn S. Winkler T. Foisy I. Tetrahedron Lett.  2000,  41:  6387 
    CrossrefGoogle Scholar
  • 11d Shutalev AD. Khim. Getero. Soed.  1993,  12:  1645 
    CrossrefGoogle Scholar
  • 11e Shutalev AD. Sivova NV. Khim. Getero. Soed.  1996,  10:  1337 
    CrossrefGoogle Scholar
  • 11f Liepa AJ. Wright DMJ. Aust. J. Chem.  2000,  53:  73 
    CrossrefGoogle Scholar
12

Formation of Polymer-Supported Urea ( 4).
A solution of the corresponding isocyanate (0.6 mmol) in anhyd DMF (2 mL) was added to resin 3 (0.06 mmol). The suspension was shaken for 5-16 h at r.t, filtered off and washed five times with DMF (3 mL) followed by five washes with CH2Cl2 (3 mL). The resin was dried under vacuum to afford the solid-phase bound urea 4. General Procedure for the Solid-Phase Synthesis of Target Molecules ( 9).
To a suspension of resin 4 (0.06 mmol) in AcOH (2 mL), 40 wt% aqueous solution of glyoxal (1.2 mmol) was added followed by addition of arylsulfinic acid sodium salt (0.6 mmol). The suspension was shaken for 16 h at r.t. or for 30 min at 80 °C. The resin was then washed ten times with CH2Cl2 (3 mL) and the product was cleaved by treatment with 80% TFA/CH2Cl2 and 4% triisopropylsilane for 16 h at r.t. The TFA solution was concentrated to afford crude product 9 that was further purified by preparative LCMS.